Stockscreener 앱 받기
55.69
1.14%
0.63
시장 영업 전:
55.93
0.24
+0.43%
전일 마감가:
$55.06
열려 있는:
$54.23
하루 거래량:
3.44M
Relative Volume:
0.55
시가총액:
$10.03B
수익:
$1.36B
순이익/손실:
$-302.91M
주가수익비율:
-32.41
EPS:
-1.7182
순현금흐름:
$-219.93M
1주 성능:
+18.36%
1개월 성능:
-4.36%
6개월 성능:
+3.88%
1년 성능:
-8.43%
1일 변동 폭
$53.00
$56.58
1주일 범위
$44.80
$56.60
52주 변동 폭
$40.77
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
명칭
Tempus Ai Inc
전화
800-976-5448
주소
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, TXG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
55.69 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
236.58 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
57.89 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
105.57 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
58.48 | 5.83B | 638.78M | -22.66M | 122.18M | -0.1744 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-13 | 개시 | Jefferies | Underperform |
| 2026-04-13 | 업그레이드 | TD Cowen | Hold → Buy |
| 2026-02-19 | 개시 | Mizuho | Outperform |
| 2026-02-17 | 개시 | Robert W. Baird | Outperform |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-10-21 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-10-20 | 개시 | Canaccord Genuity | Buy |
| 2025-09-02 | 개시 | H.C. Wainwright | Buy |
| 2025-04-21 | 개시 | BTIG Research | Buy |
| 2025-02-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-02-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | 재개 | TD Cowen | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-12-09 | 개시 | Guggenheim | Buy |
| 2024-11-11 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-10-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-12 | 개시 | Piper Sandler | Neutral |
| 2024-07-09 | 개시 | BofA Securities | Buy |
| 2024-07-09 | 개시 | JP Morgan | Overweight |
| 2024-07-09 | 개시 | Longbow | Buy |
| 2024-07-09 | 개시 | Loop Capital | Buy |
| 2024-07-09 | 개시 | Morgan Stanley | Overweight |
| 2024-07-09 | 개시 | Needham | Buy |
| 2024-07-09 | 개시 | Stifel | Buy |
| 2024-07-09 | 개시 | TD Cowen | Buy |
| 2024-07-09 | 개시 | William Blair | Outperform |
모두보기
Tempus Ai Inc 주식(TEM)의 최신 뉴스
3 Stocks That May Be Trading Below Intrinsic Value Estimates By Up To 48.5% - simplywall.st
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $1,000,800.00 in Stock - MarketBeat
Tempus AI Insider Sold Shares Worth $1,000,800, According to a Recent SEC Filing - moomoo.com
Tempus AI CEO, data Ryan Fukushima sells $1,000,800 in shares - Investing.com
Tempus AI (TEM) executive’s spouse sells 20,000 shares under 10b5-1 plan - Stock Titan
Tempus Q2 Earnings Call Highlights Data Growth and Pricing Upside - finance.yahoo.com
Bios Life leaves stealth with $25M and a Tempus alliance for cancer surveillance - The Next Web
Tempus AI (NASDAQ:TEM) Trading 7.5% HigherStill a Buy? - MarketBeat
Top Artificial Intelligence Stocks To Add to Your WatchlistAugust 10th - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: 20.35% Potential Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
Finivi Inc. Sells 24,340 Shares of Tempus AI, Inc. $TEM - MarketBeat
Tempus AI Stock (TEM) Opinions on Analyst Ratings and Portfolio Holdings - Quiver Quantitative
TEM Surges Into $1.5B MRD Deal As Stock Pulls Back - StocksToTrade
Why Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network - simplywall.st
Tempus AI Stock Drops As $1.5B Personalis Deal Ups The MRD Stakes - StocksToTrade
Tempus AI, Inc. • Robinhood Token (TEM) Price Prediction for 2026 to 2031 - Bybit
Terra Environmental (TEM): Vanessa Kubo plans $922K stock sale, details 10b5-1 trades - Stock Titan
Spotlight On Tempus AI And 2 Other Leading Insider-Owned Growth Stocks - webull.com
Tempus Hub Will Support Oncology Test Orders in CellCarta Deal - Stock Titan
Tempus AI Insider Sold Shares Worth $1,100,076, According to a Recent SEC Filing - marketscreener.com
Tempus AI (NASDAQ:TEM) Director David Epstein Sells 370 Shares of Stock - MarketBeat
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 23,818 Shares - MarketBeat
Tempus AI, Inc. (TEM) director sells 370 shares under 10b5-1 plan - Stock Titan
Piper Sandler Keeps Their Hold Rating on Tempus AI, Inc. Class A (TEM) - The Globe and Mail
Tempus AI prices $400m convertible notes offering By Investing.com - Investing.com Nigeria
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications - Business Wire
Tempus AI, Inc. Stock 12‑Month Price Target Cut to $62.21, Implies 42% Upside - TradingView
Tempus AI, Inc. (TEM) Stock Analysis: A Healthcare Tech Powerhouse with 48% Potential Upside - DirectorsTalk Interviews
InvestingPro spotted Tempus AI’s 43% decline 7 months in advance By Investing.com - Investing.com
Avidity Partners Management LP Purchases New Stake in Tempus AI, Inc. $TEM - MarketBeat
How Investors May Respond To Tempus AI (TEM) Q2 Profit Return, Outlook Hike, Personalis Deal - finance.yahoo.com
The Bull Case For Tempus AI (TEM) Could Change Following Profit Return, Outlook Hike And Personalis DealLearn Why - simplywall.st
Tempus AI (TEM) awards 40,000 RSUs to EVP and Chief Legal Officer - Stock Titan
Tempus AI, Inc. (TEM) awards 40,000 RSUs to CFO James Rogers - Stock Titan
Tempus AI, Inc. Stock 12‑Month Price Target Cut to $66.07, Implies 49% Upside - TradingView
Tempus AI Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Tempus AI Q2 Earnings Call Highlights - MarketBeat
Tempus AI, Inc. Revises Earnings Guidance for the Full Year 2026 - marketscreener.com
Tempus AI faces earnings test after $1.5B Personalis deal - Investing.com
Tempus AI buys Personalis to strengthen AI-driven cancer monitoring platform - mugglehead.com
Tempus AI (NASDAQ:TEM) Hits New 52-Week LowTime to Sell? - MarketBeat
Tempus AI Inc stock hits 52-week low at 41.7 USD - Investing.com Canada
Eagle Health Investments LP Takes Position in Tempus AI, Inc. $TEM - MarketBeat
TEM|Tempus AI Inc|Price:42.930|Chg%:+0.240 - TradingKey
Artificial Intelligence Stocks To Keep An Eye OnJuly 27th - MarketBeat
Tempus AI Stock (TEM) Opinions on Personalis Acquisition and Analyst Upgrades - Quiver Quantitative
Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring - Oncodaily
Tempus AI, Inc. (TEM) Stock Analysis: Exploring the 55.94% Potential Upside and Analyst Ratings - DirectorsTalk Interviews
Tempus AI Inc (TEM) Balance Sheet - TradingKey
AI Stocks: Why Tempus AI (NASDAQ:TEM), Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrodinger (NASDAQ:SDGR) Are in Focus - Kalkine Media
Tempus AI Inc (TEM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Tempus Ai Inc (TEM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tempus Ai Inc 주식 (TEM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Epstein David R | Director |
Aug 03 '26 |
Sale |
43.40 |
370 |
16,058 |
31,094 |
| Fukushima Ryan | CEO, Data |
Aug 03 '26 |
Sale |
46.19 |
23,818 |
1,100,076 |
143,945 |
1.14%
1.87%
자본화:
|
볼륨(24시간):